Detalhe da pesquisa
1.
Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP.
Eur J Pediatr
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771373
2.
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 194: 106859, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37473877
3.
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.
Int J Mol Sci
; 24(2)2023 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675312
4.
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.
Pharmacol Res
; 196: 106938, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748560
5.
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
Biomed Pharmacother
; 173: 116299, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401525
6.
The Role of Partial Enteral Nutrition for Induction of Remission in Crohn's Disease: A Systematic Review of Controlled Trials.
Nutrients
; 14(24)2022 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36558422
7.
V232D mutation in patients with cystic fibrosis: Not so rare, not so mild.
Medicine (Baltimore)
; 97(28): e11397, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29995784